Mesoblast Limited

MESO ·Healthcare, Drug Manufacturers - General, Australia
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $669.2M

Liabilities Breakdown FY2024

Total Liabilities: $188.8M